{"filing":{"accession_number":"0001193125-26-318069","cik":"0000944809","ticker":"OPK","company_name":"OPKO HEALTH, INC.","form":"8-K","filing_date":"2026-07-27","report_date":"2026-07-27","primary_document":"opk-20260727.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/944809/000119312526318069/opk-20260727.htm"},"events":[{"id":20682,"run_id":18617,"accession_number":"0001193125-26-318069","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"OPKO Health issued a press release on July 27, 2026 announcing operating and financial highlights for the quarter ended June 30, 2026, including consolidated total revenues of $163.5 million, operating loss of $7.0 million, and net loss of $8.4 million ($0.01 per share). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures. The company also provided 2026 third quarter and full-year financial guidance.","company_name":"OPKO HEALTH, INC.","ticker":"OPK","filing_date":"2026-07-27","form":"8-K","submitted_at":null,"items":[{"id":20117,"accession_number":"0001193125-26-318069","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"OPKO Health issued a press release on July 27, 2026 announcing operating and financial highlights for the quarter ended June 30, 2026, including consolidated total revenues of $163.5 million, operating loss of $7.0 million, and net loss of $8.4 million ($0.01 per share). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures. The company also provided 2026 third quarter and full-year financial guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-27T20:13:18.113635+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20117,"accession_number":"0001193125-26-318069","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"OPKO Health issued a press release on July 27, 2026 announcing operating and financial highlights for the quarter ended June 30, 2026, including consolidated total revenues of $163.5 million, operating loss of $7.0 million, and net loss of $8.4 million ($0.01 per share). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures. The company also provided 2026 third quarter and full-year financial guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-27T20:13:18.113635+00:00","company_name":"OPKO HEALTH, INC.","ticker":"OPK","filing_date":"2026-07-27"}]}